Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | TAR DNA binding protein | Starlite/ChEMBL | No references |
Homo sapiens | isocitrate dehydrogenase 1 (NADP+), soluble | Starlite/ChEMBL | No references |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.0118 | 0.3067 | 0.3036 |
Loa Loa (eye worm) | RNA binding protein | 0.0076 | 0.1585 | 0.1547 |
Echinococcus granulosus | ephrin type A receptor 4 A | 0.0133 | 0.3609 | 0.3609 |
Schistosoma mansoni | ephrin receptor | 0.012 | 0.3144 | 0.3113 |
Echinococcus granulosus | epidermal growth factor receptor | 0.0081 | 0.175 | 0.175 |
Echinococcus granulosus | tar DNA binding protein | 0.0076 | 0.1585 | 0.1585 |
Loa Loa (eye worm) | TK/INSR protein kinase | 0.0049 | 0.0587 | 0.0545 |
Plasmodium vivax | SET domain protein, putative | 0.0034 | 0.0045 | 0.5 |
Echinococcus multilocularis | ephrin type A receptor 4 A | 0.0133 | 0.3609 | 0.3581 |
Echinococcus granulosus | epidermal growth factor receptor | 0.015 | 0.422 | 0.422 |
Loa Loa (eye worm) | TK/EPH protein kinase | 0.0152 | 0.4304 | 0.4279 |
Toxoplasma gondii | fructose-bisphospatase II | 0.0311 | 1 | 1 |
Schistosoma mansoni | tyrosine kinase | 0.0049 | 0.0587 | 0.0545 |
Loa Loa (eye worm) | TK/EGFR protein kinase | 0.015 | 0.422 | 0.4194 |
Loa Loa (eye worm) | glutaminase 2 | 0.0308 | 0.9916 | 0.9915 |
Echinococcus multilocularis | fructose 1,6 bisphosphatase 1 | 0.0311 | 1 | 1 |
Schistosoma mansoni | tyrosine kinase | 0.0079 | 0.1672 | 0.1635 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0076 | 0.1585 | 0.1547 |
Loa Loa (eye worm) | glutaminase | 0.0308 | 0.9916 | 0.9915 |
Echinococcus multilocularis | insulin receptor | 0.0049 | 0.0587 | 0.0545 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.1585 | 0.1547 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.1585 | 0.1547 |
Schistosoma mansoni | tyrosine kinase | 0.0081 | 0.175 | 0.1713 |
Brugia malayi | Protein kinase domain containing protein | 0.0049 | 0.0587 | 0.0545 |
Schistosoma mansoni | tyrosine kinase | 0.0049 | 0.0587 | 0.0545 |
Echinococcus granulosus | insulin growth factor 1 receptor beta | 0.0053 | 0.0746 | 0.0746 |
Echinococcus granulosus | insulin receptor | 0.0049 | 0.0587 | 0.0587 |
Schistosoma mansoni | fructose-16-bisphosphatase-related | 0.0311 | 1 | 1 |
Schistosoma mansoni | tyrosine kinase | 0.0081 | 0.175 | 0.1713 |
Leishmania major | 0.0311 | 1 | 0.5 | |
Trypanosoma cruzi | fructose-1,6-bisphosphatase, cytosolic, putative | 0.0311 | 1 | 1 |
Schistosoma mansoni | glutaminase | 0.0308 | 0.9916 | 0.9915 |
Trypanosoma brucei | fructose-1,6-bisphosphatase | 0.0311 | 1 | 1 |
Trypanosoma cruzi | fructose-1,6-bisphosphatase, cytosolic, putative | 0.0311 | 1 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.1585 | 0.1547 |
Echinococcus granulosus | fructose 16 bisphosphatase 1 | 0.0311 | 1 | 1 |
Mycobacterium ulcerans | glutaminase | 0.0308 | 0.9916 | 0.5 |
Brugia malayi | TAR-binding protein | 0.0076 | 0.1585 | 0.1547 |
Brugia malayi | glutaminase DH11.1 | 0.0308 | 0.9916 | 0.9915 |
Echinococcus multilocularis | epidermal growth factor receptor | 0.0081 | 0.175 | 0.1713 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0076 | 0.1585 | 0.1547 |
Brugia malayi | Pre-SET motif family protein | 0.0235 | 0.7271 | 0.7259 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.1585 | 0.1547 |
Brugia malayi | Furin-like cysteine rich region family protein | 0.015 | 0.422 | 0.4194 |
Echinococcus multilocularis | tar DNA binding protein | 0.0076 | 0.1585 | 0.1547 |
Schistosoma mansoni | tyrosine kinase | 0.015 | 0.422 | 0.4194 |
Trichomonas vaginalis | glutaminase, putative | 0.0308 | 0.9916 | 1 |
Toxoplasma gondii | fructose-bisphospatase I | 0.0115 | 0.2987 | 0.2955 |
Schistosoma mansoni | tyrosine kinase | 0.0079 | 0.1672 | 0.1635 |
Onchocerca volvulus | 0.0267 | 0.8437 | 1 | |
Loa Loa (eye worm) | pre-SET domain-containing protein family protein | 0.0235 | 0.7271 | 0.7259 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.0988 | 0.0948 |
Onchocerca volvulus | 0.0118 | 0.3067 | 0.3601 | |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.1585 | 0.1547 |
Loa Loa (eye worm) | fructose-1,6-bisphosphatase | 0.0311 | 1 | 1 |
Brugia malayi | RNA binding protein | 0.0076 | 0.1585 | 0.1547 |
Loa Loa (eye worm) | TAR-binding protein | 0.0076 | 0.1585 | 0.1547 |
Schistosoma mansoni | tyrosine kinase | 0.0079 | 0.1672 | 0.1635 |
Echinococcus multilocularis | 0.0046 | 0.0487 | 0.0444 | |
Echinococcus granulosus | melanoma receptor tyrosine protein kinase | 0.0081 | 0.175 | 0.175 |
Echinococcus multilocularis | epidermal growth factor receptor | 0.015 | 0.422 | 0.4194 |
Brugia malayi | ephrin receptor 1 precursor | 0.0058 | 0.0906 | 0.0865 |
Toxoplasma gondii | sedoheptulose-1,7-bisphosphatase | 0.0115 | 0.2987 | 0.2955 |
Echinococcus multilocularis | insulin growth factor 1 receptor beta | 0.0053 | 0.0746 | 0.0705 |
Echinococcus granulosus | histone lysine methyltransferase setb | 0.0034 | 0.0045 | 0.0045 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 14.1254 uM | PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 16.3601 uM | PubChem BioAssay. qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 22.3872 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 25.1189 uM | PubChem BioAssay. qHTS of alpha-syn Inhibitors. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 39.8107 uM | PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.